An Italian survey on the use of denosumab for the management of skeletal-related events in patients with bone metastases
Articolo
Data di Pubblicazione:
2022
Abstract:
The Italian Association for Medical Oncology (AIOM) recommends preventive treatment of skeletal-related events in order to improve survival and the quality of life of patients with advanced malignancies. The aim of the study was to evaluate whether routine clinical practice is in agreement with recommendations about the use of denosumab.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Denosumab; Diphosphonates; Humans; Male; Quality of Life; Bone Density Conservation Agents; Bone Neoplasms; Lung Neoplasms
Elenco autori:
Berardi, R; Berruti, A; Brogelli, L; Zucali, P A
Link alla scheda completa:
Pubblicato in: